Susquehanna International Group
FBRX icon

Susquehanna International Group’s Forte Biosciences FBRX Stock Holding History

Susquehanna International Group’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$593K Buy
+22,900
New +$660K ﹤0.01% 9230
2022
Q3 		– Sell
-40,308
Closed -$1.31M – 13441
2022
Q2 		$1.31M Buy
+40,308
New +$1.28M ﹤0.01% 5873
2022
Q1 		– Sell
-2,560
Closed -$137K – 13256
2021
Q4 		$137K Sell
2,560
-8,020
-76% -$539K ﹤0.01% 11892
2021
Q3 		$783K Buy
+10,580
New +$5.86M ﹤0.01% 8194
2020
Q2 		– Sell
-33
Closed -$15K – 10324
2020
Q1 		$15K Sell
33
-7
-18% -$2.73K ﹤0.01% 9988
2019
Q4 		$8K Sell
40
-178
-82% -$40.3K ﹤0.01% 9561
2019
Q3 		$54K Sell
218
-18
-8% -$27.3K ﹤0.01% 9750
2019
Q2 		$591K Buy
236
+171
+263% +$507K ﹤0.01% 6926
2019
Q1 		$263K Sell
65
-2
-3% -$7.73K ﹤0.01% 7435
2018
Q4 		$207K Buy
67
+5
+8% +$21.5K ﹤0.01% 7673
2018
Q3 		$360K Sell
62
-94
-60% -$358K ﹤0.01% 7114
2018
Q2 		$545K Buy
156
+73
+88% +$267K ﹤0.01% 6611
2018
Q1 		$371K Sell
83
-24
-22% -$111K ﹤0.01% 7240
2017
Q4 		$410K Buy
+107
New +$427K ﹤0.01% 7008

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Susquehanna International Group's FBRX Position: Q1 2026 in Review

Susquehanna International Group increased its Forte Biosciences (FBRX) stake by 152% in Q1 2026, buying an estimated $2.32M and bringing the position to 133,494 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #4977.

Susquehanna International Group first reported a position in FBRX in Q1 2018 and has held it in 17 quarters since. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Susquehanna International Group held 133,494 shares of Forte Biosciences worth $3.46M as of Q1 2026.
  • Susquehanna International Group bought 80,580 Forte Biosciences shares in Q1 2026, an estimated $2.32M.
  • Forte Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4977 holding.
  • Susquehanna International Group first reported a position in Forte Biosciences in Q1 2018 and has held it in 17 quarters since.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.